BioGenex

14 articles about BioGenex

• BioGenex, Inc. Introduces PD1 And PDL-1 Antibodies For Immunohistochemistry (IHC)

  3/8/2017

• A Novel, Quantitative Immunohistochemistry Method Enabled By BioGenex, Inc. IHC System

  2/17/2017

• BioGenex, Inc. Introduces All-in-One All-at-Once Antigen Retrieval Elegance System

  1/9/2017

• BioGenex, Inc. Boosts Genome Research And Diagnostics With The Launch Of The Xmatrx Mini For Simplified FISH, ISH, And In Situ PCR Analysis Of Histology And Cytology Specimens

  6/16/2016

• BioGenex, Inc. Launches Two New Antibodies For Cancer Diagnosis

  4/4/2016

• BioGenex, Inc. Will Introduce Fully Integrated Mirna-ISH System For Tumor Diagnosis And Clinical Research At The USCAP Annual Meeting In Seattle, WA

  3/7/2016

• BioGenex, Inc. Launches The Integrated eFISHiency System For The Analysis Of Solid Tumors And Hematological Malignancies With Streamlined & Simplified Protocol

  3/1/2016

• BioGenex, Inc. Completes Construction Of A State-Of-The-Art Center For Cancer Diagnostics And Molecular Pathology Innovation In Hyderabad, India

  2/16/2016

• BioGenex, Inc. and Abbott Molecular, Inc. Conclude Successful Partnership

  3/4/2013

• Abbott Laboratories, BioGenex, Inc. Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays

  6/2/2009

• BioGenex, Inc., Ventana Medical Systems, Inc. Settle Patent Litigation

  6/4/2007

• BioGenex, Inc.'s Xmatrx(TM) System Provides Significant Advantage For Research

  11/15/2005

• Microtome To Microscope - The Xmatrx(TM) System From BioGenex, Inc.

  11/8/2005

• BioGenex, Inc. To Launch The Xmatrx(TM) Automated Staining System

  11/1/2005